论文部分内容阅读
目的:分析两种方案治疗季节性过敏性结膜炎的临床疗效及经济性,指导临床合理用药。方法:66例季节性过敏性结膜炎患者随机分为:Ⅰ组33例(0.1%盐酸奥洛他定)和Ⅱ组33例(0.05%依美斯汀联合0.1%洛度沙胺,33例)治疗后观察疗效,并进行最小成本分析。结果:Ⅰ组和Ⅱ组的治疗总有效率分别为93.94%和90. 91%,两者间差异无显著性(P>0.05);治疗药物成本分别为(154.39±9.65)元和(104.09±3.56)元,两者间差异有显著性(P<0.05)。结论:依美斯汀联合洛度沙胺方案治疗季节性过敏性结膜炎是一种有效、经济的方法。
OBJECTIVE: To analyze the clinical efficacy and economy of the two regimens in the treatment of seasonal allergic conjunctivitis and to guide clinical rational use of drugs. Methods: Sixty-six patients with seasonal allergic conjunctivitis were randomly divided into three groups: 33 patients in group Ⅰ (0.1% olopatadine hydrochloride) and 33 patients in group Ⅱ (33% 0.05% emamectin combined with 0.1% After treatment, the curative effect was observed and the minimum cost analysis was performed. Results: The total effective rates of group Ⅰ and group Ⅱ were 93.94% and 90.91%, respectively. There was no significant difference between the two groups (P> 0.05). The cost of treatment was (154.39 ± 9.65) yuan and (104.09 ± 3.56) yuan, the difference was significant (P <0.05). Conclusion: Emestine combined with drospirenamide regimen is an effective and economical method for the treatment of seasonal allergic conjunctivitis.